Catherine Lewis La Torre appointed CEO, British Patient Capital
Press release
Catherine Lewis La Torre has been appointed CEO of British Patient Capital, returning to the role she held from 2018 until 2020 before she was named as acting CEO of the British Business Bank in September of that year.
Catherine has also been appointed as Chair of British Business Investments, taking over from Francis Small who recently concluded his term in office. In addition, Catherine has taken on the role of Senior Responsible Officer for the Bank’s other equity schemes.
Following the recent announcement that Louis Taylor will be joining as the Bank’s new CEO in October, Catherine will continue as acting CEO to ensure an orderly transition, taking up her new roles in the autumn.
Judith Hartley, who was appointed acting CEO of British Patient Capital and British Business Investments in September 2020, will take up the permanent role of CEO, British Business Investments when her secondment ends in the autumn.
I would like to congratulate Catherine and Judith on their new roles. The Board is confident that these appointments will continue to strengthen the leadership of the Bank and help us deliver on our mission to drive sustainable growth and prosperity across the UK, and to enable the transition to a net zero economy, by improving access to finance for smaller businesses. Lord Smith of Kelvin Chair, British Business Bank,
I am delighted to be leading British Patient Capital in the next chapter of its development. Our mission is to enable long-term investment in innovative companies across the UK led by ambitious entrepreneurs who want to build successful, world-class businesses. As we are the UK’s largest domestic investor in venture and growth capital today, I look forward to working with British Patient Capital’s talented investment team so that more UK companies can raise the capital they need to scale up and reach their full potential. Catherine Lewis La Torre CEO, British Patient Capital
Further Information
Latest news
-
Read more about British Patient Capital announces $50.8m commitment to Evolution Technology Fund III Press release
25 April 2024 -
Read more about British Patient Capital announces £7m investment in Financial Wellbeing Fintech - Wagestream Press release
17 April 2024 -
Read more about British Patient Capital announces £5.5m commitment to Phagenesis Press release
04 March 2024